Rookie-----Phase 1. Get in the game. Stop creamin all over your shorts on this one. Go ahead---get excited. But this is way too early to get all jacked up. Sellick hasn't delivered in 13 years----FOCUS ON PHASE 3-----IS THAT TOO DIFFFICULT FOR YOUR TINY LITTLE KERNAL ??? Have you NOT learned ANYTHING about biotech ???? Stay with your press releases---not everybody reads them. No more comments on Dendreon either---they went BANKRUPT. Did anybody tell you ??? HAAHHAHAHHAHAHAHAHAHAHHAHA
Good to see you can READ the press releases little rookie. Maestro is PHASE 3------not some Phase 1 study in Japan. Do you ever know what day it is ???
Good to see little rookie is back to doing what it does best----repost press releases. You are obviously new or maybe just naieve as far as biotechs are concerned. With a very high percentage of Phase 1 studies never making it to the ultimate market place----only a rookie would jump up & down in excitement over the Japanese trial. Pay attention to Phase THREE results dumb-dumb. Maybe just maybe THLD stands a SHOT AT SOME DECENT NEWS. As far as your hero Sellick---the guy is LUCKY he still has a job----as he's been a disaster over the last THIRTEEN YEARS----getting NOTHING done. Is he your step-father or something ?
any impact from the investors there ? how would YOU guage that ? off of the website slide show ?
Short squeeze ??? you using big financial terms again ? how does such a little person like you know so much ? short squeeze ? funneeeeee
you're on the wrong board rookie
Decent turnout & it seemed like it was a new story for some in attendance. If Cowen ever got behind this it would certainly help with the professional healthcare investors.
ALXN is growing 30%+ and looks poised to accelerate growth with new product approvals on the horizon. Looks like you need to stop looking in the rear view mirror.
no significance rookie. THLD will not move off of tiny retail "players" but that may be too complicated for you to understand.
AAL is likely the buyer of shares under $50. Cowen trading desk caught short ? are you for real or just new to the markets ? AAL has hardly been running away on the upside. Cowen has been one of the big bulls on the name.